Novira Therapeutics Garners $7,500,000 Series A Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6fa1f7e2-55a9-4897-8839-2de78ce92a97&Preview=1
Date
3/26/2013
Company Name
Novira Therapeutics
Mailing Address
Undisclosed Los Angeles, CA 90041
Company Description
Novira is an antiviral drug discovery company launched in 2009 that is focused on the discovery of novel, first-in-class therapeutics for the treatment of HBV and HIV, two global diseases in need of better therapies. The company is led by seasoned pharmaceutical industry executives with proven records of success in drug discovery. The company has identified and is further optimizing a promising pipeline of drugs that disrupt virus capsid assembly of HIV and HBV using an efficient and innovative model of biomedical research.
Website
http://www.noviratherapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$7,500,000
Transaction Round
Series A
Proceeds Purposes
We plan to use these funds to advance development of our hepatitis B virus (HBV) capsid inhibitor lead program toward the clinic and to discover additional HBV drug candidates.
M&A Terms
Venture Investor
Versant Ventures